160 related articles for article (PubMed ID: 38164262)
21. Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice.
Tan L; Han S; Ding S; Xiao W; Ding Y; Qian L; Wang C; Gong W
Int J Nanomedicine; 2017; 12():3095-3107. PubMed ID: 28450784
[TBL] [Abstract][Full Text] [Related]
22. Poly(ethylene glycol)/poly(epsilon-caprolactone) diblock copolymeric nanoparticles for non-viral gene delivery: the role of charge group and molecular weight in particle formation, cytotoxicity and transfection.
Jang JS; Kim SY; Lee SB; Kim KO; Han JS; Lee YM
J Control Release; 2006 Jun; 113(2):173-82. PubMed ID: 16750279
[TBL] [Abstract][Full Text] [Related]
23. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
24. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
25. DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells.
Khodaei M; Rostamizadeh K; Taromchi AH; Monirinasab H; Fathi M
Clin Transl Oncol; 2021 Jun; 23(6):1167-1178. PubMed ID: 33389648
[TBL] [Abstract][Full Text] [Related]
26. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
27. Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
Men K; Liu W; Li L; Duan X; Wang P; Gou M; Wei X; Gao X; Wang B; Du Y; Huang M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Oct; 4(20):6425-33. PubMed ID: 22955255
[TBL] [Abstract][Full Text] [Related]
28. IL-22BP controls the progression of liver metastasis in colorectal cancer.
Giannou AD; Kempski J; Zhang T; Lücke J; Shiri AM; Zazara DE; Belios I; Machicote A; Seeger P; Agalioti T; Tintelnot J; Sagebiel A; Tomczak M; Bauditz L; Bedke T; Kocheise L; Mercanoglu B; Fard-Aghaie M; Giorgakis E; Lykoudis PM; Pikouli A; Grass JK; Wahib R; Bardenhagen J; Brunswig B; Heumann A; Ghadban T; Duprée A; Tachezy M; Melling N; Arck PC; Stringa P; Gentilini MV; Gondolesi GE; Nakano R; Thomson AW; Perez D; Li J; Mann O; Izbicki JR; Gagliani N; Maroulis IC; Huber S
Front Oncol; 2023; 13():1170502. PubMed ID: 37324022
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
30. Optimization of DOTAP/chol Cationic Lipid Nanoparticles for mRNA, pDNA, and Oligonucleotide Delivery.
Sun M; Dang UJ; Yuan Y; Psaras AM; Osipitan O; Brooks TA; Lu F; Di Pasqua AJ
AAPS PharmSciTech; 2022 May; 23(5):135. PubMed ID: 35534697
[TBL] [Abstract][Full Text] [Related]
31. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
[TBL] [Abstract][Full Text] [Related]
32. Local and Systemic Delivery of the BimS Gene Nano-Complex for Efficient Oral Squamous Cell Carcinoma Therapy.
Ma P; Li J; Gao Y; Wu J; Men K; Li C; Men Y; Duan X
Int J Nanomedicine; 2022; 17():2925-2941. PubMed ID: 35814613
[TBL] [Abstract][Full Text] [Related]
33. Development of cell-penetrating peptide-modified MPEG-PCL diblock copolymeric nanoparticles for systemic gene delivery.
Tanaka K; Kanazawa T; Shibata Y; Suda Y; Fukuda T; Takashima Y; Okada H
Int J Pharm; 2010 Aug; 396(1-2):229-38. PubMed ID: 20600726
[TBL] [Abstract][Full Text] [Related]
34. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine.
Huber S; Gagliani N; Zenewicz LA; Huber FJ; Bosurgi L; Hu B; Hedl M; Zhang W; O'Connor W; Murphy AJ; Valenzuela DM; Yancopoulos GD; Booth CJ; Cho JH; Ouyang W; Abraham C; Flavell RA
Nature; 2012 Nov; 491(7423):259-63. PubMed ID: 23075849
[TBL] [Abstract][Full Text] [Related]
35. Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
Huang W; Liu Z; Zhou G; Tian A; Sun N
Oncol Rep; 2016 Feb; 35(2):978-84. PubMed ID: 26717967
[TBL] [Abstract][Full Text] [Related]
36. Low Interleukin-22 Binding Protein Is Associated With High Mortality in Alcoholic Hepatitis and Modulates Interleukin-22 Receptor Expression.
Støy S; Laursen TL; Glavind E; Eriksen PL; Terczynska-Dyla E; Magnusson NE; Hamilton-Dutoit S; Mortensen FV; Veidal SS; Rigbolt K; Riggio O; Deleuran B; Vilstrup H; Sandahl TD
Clin Transl Gastroenterol; 2020 Aug; 11(8):e00197. PubMed ID: 32955203
[TBL] [Abstract][Full Text] [Related]
37. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
38. Successful immunogene therapy using colon cancer cells (colon 26) transfected with plasmid vector containing mature interleukin-18 cDNA and the Igkappa leader sequence.
Yoshimura K; Hazama S; Iizuka N; Yoshino S; Yamamoto K; Muraguchi M; Ohmoto Y; Noma T; Oka M
Cancer Gene Ther; 2001 Jan; 8(1):9-16. PubMed ID: 11219497
[TBL] [Abstract][Full Text] [Related]
39. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
40. Blocking hepatic metastases of colon cancer cells using an shRNA against Rac1 delivered by activatable cell-penetrating peptide.
Bao Y; Guo H; Lu Y; Feng W; Sun X; Tang C; Wang X; Shen M
Oncotarget; 2016 Nov; 7(47):77183-77195. PubMed ID: 27791203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
